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Available online 20 July 2011AbstractBackground: In evaluating follow-up of early breast cancer, patients’ views on care are important. The aim of this study was to evaluate the
effect of the introduction of nurse practitioners (NPs) in a breast cancer unit on patients’ informational needs, preferences and attitude to-
wards follow-up.
Patients and methods: A cross-sectional survey was performed among two groups in 2005. Group A (n ¼ 89) consisted of patients operated
before, and group B (n ¼ 100) after the introduction of a breast cancer unit (respectively in 1998e1999 and 2001e2004).
Results: Response was 72% in group A and 84% in group B. Median follow-up was 69 (54e86) and 33 (0e57) months, respectively. As-
pects highly appreciated by patients in both groups were lifetime follow-up, information about prognosis, life style and additional inves-
tigations. Important discussion subjects were fatigue, pain, genetic factors, prevention and arm function/lymph-oedema. Less valued aspects
were information about peers, conversations with psychologists or social workers, breast reconstruction, and acceptation by family mem-
bers. The informational needs and preferences did not differ statistically significantly between both groups. In group B, communication
with the caregiver was valued higher and more patients indicated that the caregiver took the time needed. More patients in group B indi-
cated that follow-up could be performed by the NP. Duration of follow-up correlated with preferred frequency, not with informational needs
in follow-up, only young age increased these needs.
Conclusion: Despite the limitations of this retrospective study, we conclude that while expectations and informational needs did not change
with the introduction of a NP to the standard care, patient satisfaction increased and communication and time taken were appreciated more.
 2011 Elsevier Ltd. All rights reserved.
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Early breast cancer patients are followed in a routine
follow-up programme after intently curative treatment.
This programme has four aims1,2; first, to detect recur-
rences at an early stage. Second, to detect early and late
complications of treatment. Third, to offer psychosocial
support to the patient to optimise quality of life, and last,
to assess treatment outcome for research purposes.* Corresponding author. Tel.: þ31 71 5261990; fax: þ31 71 5266760.
E-mail address: m.van_hezewijk@lumc.nl (M. van Hezewijk).
0748-7983/$ - see front matter  2011 Elsevier Ltd. All rights reserved.
doi:10.1016/j.ejso.2011.06.007It is generally accepted that the elements of routine
follow-up are periodic visits for history and physical exam-
ination and annual surveillance mammograms.1,3
Due to better therapeutic strategies and increasing age of
the population, numbers of breast cancer survivors increase
over the years. Therefore, the need for routine visits is recon-
sidered as they will become a burden for both professionals
and patients. Alternative strategies in follow-up have been
proposed, including primary care involvement, less-
intensive and shorter follow-up schedules and the introduc-
tion of specialised breast cancer nurses or nurse practitioners
to perform the follow-up.4e9 In an increasing number of
766 M. van Hezewijk et al. / EJSO 37 (2011) 765e773practices in the Netherlands, these nurse practitioners or
breast care nurses have become part of standard care.10
To implement new follow-up schedules, evaluation of
patients’ preferences and their opinion on the current prac-
tice is very important. Although patients’ satisfaction with
follow-up and quality of life have been studied, few studies
have focused on patients’ specific informational needs and
preferences and attitude towards follow-up in breast cancer
follow-up and their views on nurse practitioners.2,8,11e15
We conducted this study to evaluate patients’ views on
the changing role of the nurse practitioner and their needs
and preferences with different follow-up duration.Aim of studyThis study is a cross-sectional study to investigate pa-
tients’ information needs and preferences regarding organi-
sation of follow-up care and their satisfaction with care
after treatment. We compared the results between patients
treated before and after the introduction of the nurse prac-
titioner in their treatment at the breast cancer unit in 2001
and evaluated the determinants of these needs and
preferences.
Patients and methodsOrganisation of follow-upAll patients participated in a standard routine follow-up
schedule according to the Dutch national guidelines for
breast cancer (www.oncoline.nl). This follow-up schedule
recommends visits every three months during the first
year, every six months during the second year and once
a year until at least five years after treatment. Mammo-
grams are performed annually. In our hospital, a multidisci-
plinary breast cancer unit started in 2001. Patients already
in follow-up at that time were seen routinely by their treat-
ing surgeon and radiation oncologist and only incidentally
by a nurse practitioner. After the start of the breast cancer
unit, there was a major change in the role of the nurse prac-
titioners. They now play a central role in the pre- and post-
operative patient care, including information on surgery
and adjuvant systemic treatment, and follow-up. Patients
can still be seen by their treating physician, alternately
with the NP. A physician is always available to the NPs
for advice if necessary. All follow-up visits, either per-
formed by the NP or a physician are scheduled for
15 min. After the introduction of the breast cancer unit, ad-
ditional written information about their treatment became
available for patients. Furthermore, all new patients are dis-
cussed in a multidisciplinary meeting.PatientsAll patients included in this study had been treated for
early breast cancer, were participating in the routinefollow-up, and were free of recurrence when sending the
questionnaires in 2005. The first group, group A, consisted
of patients operated before the introduction of the breast
cancer unit (1998e1999, n ¼ 89) and had previously partic-
ipated in a patient satisfaction survey in 2004.2 These pa-
tients were only incidentally seen by a nurse practitioner.
The second group, group B, consisted of patients operated
after the introduction of the breast cancer unit (2001e2004,
n ¼ 100) and were randomly selected from the 280 patients
treated for early breast cancer in that period. These patients
were routinely seen by a nurse practitioner. Patients had
been treated with local and systemic therapy according to
national guidelines.3 For patient characteristics see Table 1.QuestionnaireThe questionnaire we used was previously developed
and described.2
The first part of the questionnaire consisted of sociode-
mographic questions and medical history (stage of breast
cancer, local and systemic therapy). The next part was a val-
idated questionnaire on patients’ attitude towards follow-
up.2,16 This questionnaire consists of four subscales: com-
munication (with the physician), reassurance, nervous an-
ticipation, and specific perceived disadvantages of follow-
up. All scales are on a range of 0e100. For the communi-
cation and the reassurance scales, a higher score means
a more positive evaluation. For the nervous anticipation
and the disadvantages scales, a higher score means more
negative effects. The third part of the questionnaire in-
cluded items on the expected benefits of follow-up, from
a patient’s perspective, regarding the purposes of breast
self-examination, breast examination by a doctor, mam-
mography, and the patient’s ideas about the curability of
the disease after the detection of distant metastases (eight
items in total). Answers were given on a four point scale:
(1) not at all, (2) somewhat, (3) rather, and (4) very
much. The fourth part consisted of 13 items concerning or-
ganisation of follow-up visits (current and preferred fre-
quency, duration, oncologist versus nurse practitioner and
additional tests). The fifth part contained items concerning
needs and preferences in routine follow-up. These were
subdivided into two main categories: information needs
and medical technical preferences with respect to follow-
up. The items had to be answered on a three point scale:
(1) not important/do not wish this, (2) not very important/
do not care, and (3) very important/I certainly want this.
Two subscales were used based on previous research2:
one for general topics and one for more specific topics.
Per scale the scores were added up. The higher the score,
the higher the informational needs. Subsequent items exam-
ined patient satisfaction with oncologic care using the
Dutch version of Ware’s Patient Satisfaction Questionnaire
III (PSQ III).17 This questionnaire (43 items) was designed
to measure technical competence, interpersonal manner,
and access to care. To get an impression of the general
Table 1
Patient and treatment characteristics.
Characteristics Group Aa (N ¼ 60) Group Ba (N ¼ 81) p-valuec
n % n %
Age in years 0.09
Median (range) 57 (32e85) 54 (28e73)
Follow-up in months <0.001
Median (range) 69 (54e86) 33 (0e57)
Pathological Tumour stage 0.67
Tis 8 1 15 19
T1 33 55 43 54
T2 19 32 22 28
Local therapy, breast 0.33
Mastectomy
Radiotherapy 30 50 29 36
þRadiotherapy 7 12 12 15
BCSb
Radiotherapy 0 0 1 1
þRadiotherapy 23 39 39 48
Local therapy, axilla <0.001
SLNBb yes 7 12 33 42
ALNDb yes 44 75 35 45
Systemic therapy 0.92
Chemotherapy alone 8 13 13 16
Endocrine therapy alone 5 8 5 6
Both 10 17 12 15
None 37 62 51 63
Quality of life and psychological functioning
QoLb on visual analogue scale; median (range) 85 (0e100) 80 (0e100) 0.21
HADS anxiety; mean; s.e. (range) 4.7 0.4 (0e14) 5.2 0.3 (0e15) 0.31
HADS depression; mean; s.e. (range) 2.0 0.5 (0e18) 1.9 0.3 (0e9) 0.91
Missing data not shown.
a Group A, consisted of patients operated before the introduction of the breast cancer unit (1998e1999). Group B, consisted of patients operated after the
introduction of the breast cancer unit (2001e2004).
b BCS ¼ Breast conserving therapy, SLNB ¼ Sentinel Lymph node biopsy, ALND ¼ Axillary lymph node dissection, QoL ¼ Quality of Life.
c Chi-quare test was used for percentages, students-t test for continuous variables.
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III. Higher score means more satisfaction with the onco-
logic care received (range: 0e100).
The seventh part of the questionnaire consisted of the
Dutch version of the HADS18 to asses anxiety and depres-
sion. The higher the score, the more anxious and depressed
the patient (range: 0e14). Last, quality of life was scored
by means of a visual analogue scale (a 100 mm horizontal
line, anchored at the extremes by ‘best imaginable quality
of life’ and ‘worst imaginable quality of life’).19Statistical analysisAll data were analysed using the statistical package
SPSS for Windows 16.0 (SPSS Inc, Chicago, IL, USA). De-
scriptive data are given as mean (SD) or median (range).
Pearson’s chi-square test was used to compare frequencies
between groups and t-test’s were done to compare continu-
ous variables between the two groups. All testing was two-
tailed with 0.05 as level of significance. Cut-offs for the
Hospital Anxiety and Depression Scale (HADS) were 8
points, based on Carroll et al.20 For all scales, missing
data were replaced by the individual mean for that scale
if no more than 50% of the items on the scale were missing;otherwise, the entire scale was considered missing. Be-
tween needs and preferences for follow-up on the one
hand and patient characteristics on the other, Spearman’s
rank correlations were calculated. Finally, for patient char-
acteristics that correlated borderline significantly with
needs or preferences (p < 0.10), a multivariable model
was constructed and b’s were calculated.
ResultsPatientsThe questionnaire was returned by 72% (64/89) in group
A and by 84% (84/100) in group B. Four respondents in
group A and three in group B were excluded from analysis,
because they had stage three disease. Patients with in situ
carcinoma were included as they were considered to have
the same treatment and follow-up as early invasive breast
cancer patients. Analyses were done in 141 patients; 60
in group A and 81 in group B. We have no information
on non-responders.
Median follow-up was 69 (54e86) months in group A
and 33 (0e57) months in group B. Patient and tumour char-
acteristics are shown in Table 1. No significant differences
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istics, treatment of the breast and systemic therapy. The dif-
ferences found in axillary treatment and in follow-up time
can be explained by the different treatment periods.Quality of life and psychological functioningQuality of life (visual analogue scale) scored high: a me-
dian score of 85 in group A and 80 in group B (p ¼ 0.21)
(Table 1). The mean scores on the HADS for anxiety and
depression were respectively 4.7 and 2.0 in group A and
5.2 and 1.9 in group B (n.s.) (Table 1). Using the cut-off
of eight for the anxiety and depression subscales,20 15%
in group A and 16% in group B would need psychiatric
evaluation for anxiety (p ¼ 0.9) and respectively 8% and
5% (p ¼ 0.4) for depression. A total of 5% had scores
higher than 11 on the HADS anxiety and were likely to
have an anxiety disorder based on DSM-IV criteria, no sta-
tistically significant differences between the groups. MoreTable 2
Attitude towards and expected benefits from follow-up.
Characteristics Group Aa (N ¼ 60)
n %
Attitude towards follow-up; mean(SD)
Fear of recurrence 33 (19
Communication with caregiver 80 (19
Nervous anticipation 16 (16
Reassurance 72 (21
Perceived disadvantages of follow-up 14 (14




To what extend do think that.
PEb will detect a new tumour in
the other breast?
35 65
PE will detect a new tumour in
the operated breast?
26 74
Mammography will detect a new
tumour in the other breast?
10 90
Mammography will detect a new
tumour in the operated breast?
9 91
Self-examination will detect a new
tumour in your breast?
40 60
Early detection of a new tumour in
the other breast will contribute
to your cure?
6 94
Early detection of metastases in the
other breast will contribute to your cure?
6 94
Early detection of a new tumour in the
operated breast will contribute to your cure?
4 96
Patient Satisfaction Questionnaire III: mean; s.e. (range)
Technical competence 71; 2 (37e100)
Interpersonal aspects 74; 3 (23e100)
Access to care 70; 2 (31e100)
Total score 75; 3 (20e100)
a Group A, consisted of patients operated before the introduction of the breast
introduction of the breast cancer unit (2001e2004).
b PE ¼ Physical examination.patients in group A than in group B (5% versus 0%) would
classify for a depression disorder (p ¼ 0.04).Attitude and benefitsAttitudes towards follow-up differed significantly be-
tween the two groups on two subscales (Table 2). Commu-
nication with the caregiver scored higher in group B than in
group A (resp. 89 versus 80, p ¼ 0.002), as did nervous an-
ticipation before follow-up (23 versus 16, p ¼ 0.04).
In detail, more patients in group B ‘very much’ agreed to
the question whether the physician or nurse practitioner
took enough time during their visit compared to group A
(66 vs. 35%, p ¼ 0.02). No other statistically significant
differences between the groups on attitude towards
follow-up were found on individual items (data not shown).
Patients had high expected benefits from follow-up in both
groups with no significant differences between both groups
(Table 2). Especially mammography was thought to detectGroup Ba (N ¼ 81) p (chi-square)
n %
) 39 (20) 0.25
) 89 (15) 0.002
) 23 (20) 0.04
) 75 (20) 0.33















79; 2 (40e100) 0.003
81; 2 (14e100) 0.03
76; 2 (38e100) 0.05
78; 2 (0e100) 0.51
cancer unit (1998e1999). Group B, consisted of patients operated after the
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tients believed early detection of a recurrence or new tumour
would contribute to their cure. Early detection of distant me-
tastases was believed to contribute to cure by more than 95%
of all patients. Less expected benefit was found for self-
examination of the breast, as little over half of all patients
thought that would detect a new tumour (Table 2).Satisfaction with oncological careIn both groups, patients were satisfied with the general
care received, with a median score of 75 and 78 for groupTable 3
Needs and preferences during follow-up visits.
Not important/do not
want this (%)
Group Aa Group Ba
General topics
How much would you like the following
topics to be part of the follow-up visit?
Information on own prognosis 4 5
Information on side effects of treatment 4 7
Information on the long term effect
of treatment
4 10
Additional investigations (e.g. X-ray,
blood tests)
8 6




How much would you like to talk
about the following
subjects during follow-up visits?
Prevention of breast cancer 9 13
Changes in untreated breast 13 19
Hereditary factors 14 16
Arm function/lymph oedema 13 22
Pain (e.g. nerve pain) 21 18
Fatigue 12 16
Fear 25 20
Use of OAC or HTb 38 35
Dietary advise 22 17
Breast reconstruction 41 49
Acceptation by family/friends 49 33
How much would you like the following
topic to be part of the follow-up visits?






Consultation with hospital social worker 42 39
Consultation with pastoral care provider 68 71
Organisation
Every Year (%)
How often would you prefer to attend
a routine control visit?
63 28
5 years (%)
For how long would you prefer to attend
routine control visits?
5 9
a Group A, consisted of patients operated before the introduction of the breast c
introduction of the breast cancer unit (2001e2004).
b OAC ¼ Oral Anticonceptiva, HT ¼ Hormonal replacement therapy.A andB on the PSQ respectively (n.s.) (Table 2). Both groups
were most satisfied with the interpersonal aspects, but a sig-
nificant difference was found between the groups (74 vs 81,
p¼ 0.03). Also on the other subscales of satisfaction (techni-
cal competence and access to care), a significant difference
was found in favour of the group treated after the introduction
of the breast cancer unit (group B) (Table 2).Needs and preferences; contentAspects highly appreciated by patients to be part of the
follow-up programme were information about prognosis,Not very important/do
not care (%)
Very important/I
certainly want this (%)
p (chi-
square)
Group A Group B Group A Group B
10 12 85 83 0.92
10 11 86 81 0.73
20 16 77 74 0.47
29 20 63 75 0.41
35 32 58 57 0.58
28 24 63 63 0.76
29 19 58 63 0.43
30 20 57 64 0.51
21 24 66 54 0.43
21 29 59 53 0.60
38 27 50 57 0.47
33 36 43 44 0.82
22 28 41 37 0.78
49 46 29 37 0.66
26 22 33 29 0.75
38 50 14 17 0.29
25 33 19 15 0.59
34 27 4 13 0.26
44 49 15 12 0.81
28 24 4 6 0.84
Every 6 months (%) Every 3 months (%)
30 50 5 16 <0.001
10 years (%) Lifelong (%)
29 21 64 65 0.24
ancer unit (1998e1999). Group B, consisted of patients operated after the
770 M. van Hezewijk et al. / EJSO 37 (2011) 765e773side effects, life style habits and additional investigations
(Table 3). Important discussion subjects were fatigue,
pain, genetic factors, prevention of breast cancer and arm
function/lymph oedema. Less valued aspects were informa-
tion about peers, conversations with psychologists or social
workers, breast reconstruction, and acceptation by family
members. There were no statistically significant differences
between the two patient groups.Needs and preferences; frequency, duration and
professionals involvedGroup A preferred less frequent follow-up than group B.
Preference for duration of follow-up did not differ between
the groups, with almost two thirds in both groups preferring
life long follow-up visits (Table 3).
Follow-up was performed by different groups of profes-
sionals: surgical oncologists, radiation oncologists, medical
oncologists and nurse practitioners. There was no general
preference for follow-up by a single group of professionals.
Follow-up by a general practitioner was however seldom
preferred (Table 4). More patients in group B indicated
that they preferred follow-up by the nurse practitioner: 58
versus 32% (p ¼ 0.003). No difference was found in the
preference for other professionals.Determinants of need and preferencesIn bi-variate analysis, higher informational needs were
correlated with more nervous anticipation before follow-
up, higher fear of recurrence, lower quality of life, and higher
anxiety level on the HADS anxiety scale (Table 5A). Lower
informational needs were correlated with higher age, higher
patient satisfaction on the interpersonal aspects, access to
care subscale, and overall scale of the PSQ questionnaire.
Preference for more additional investigations correlated
with a higher quality of life and was lower with higher age.
Lower preferred frequency of follow-up was correlated
with longer time since diagnosis and high preferred fre-
quency with good access to care. Preferred shorter duration
was correlated with radiotherapy and long duration with
higher sense of reassurance after follow-up (Table 5A).
In multivariable analysis, only young age remained an
independent factor for high specific informational needs
and longer time since diagnosis for lower preferred
follow-up frequency (Table 5B).Table 4
Preference for type of professional.
Surgeon Radiation Oncologist Medica
Group (%) Aa Ba A B A
By whom should the follow-up be performed?
Yes 39 45 29 35 61
No 61 55 71 65 39
p-value (chi-square) 0.59 0.59 0.34
a Group A, consisted of patients operated before the introduction of the breast
introduction of the breast cancer unit (2001e2004).Discussion
In this study we examined the needs and preferences in
follow-up care among early breast cancer patients and com-
pared these at two time points in follow-up and before and
after the introduction of a breast care unit with the in-
creased role of the nurse practitioner.Needs and preferences; contentAspects highly appreciated by both groups were informa-
tion about long-term prognosis, side effects, prevention and
life style advice.This is in linewith previous research suggest-
ing a shift from disease-related information needs to informa-
tion on long term effects in the first year of follow-up.21
Patients in both groups still indicated additional investi-
gations (like chest X-ray or lab testing) to be important, as
found previously.2,11,13e15 This suggests that patients
wrongly believe that finding distant metastases at an early
stage will improve their prognosis, while in fact research
shows that detecting metastases at an early stage will not
increase survival and will decrease quality of life.22e26
This preference and expectation did not differ between
the groups, so it was not influenced by written information
or information given by nurse practitioners that patients in
group B received. This might be explained by the fact that
a large group of patient does not understand the written in-
formation available to them.27 We can conclude that even
more emphasis should be given on this subject to adjust pa-
tients’ expectations.
Less valued aspects in follow-up were consultation by
a psychologist or social worker, although one in six patients
in both groups qualifies for psychological evaluation of
anxiety or depression based on their HADS score. Patients
also did not appreciate enquiries about acceptation of fam-
ily and friends or information about peers although some
studies suggest that patients use narratives from fellow pa-
tients to cope with emotions and impact of cancer in daily
life.28Needs and preferences; frequency and duration and
professional involvedIn a previous publication, patients in group A preferred
multiple follow-up visits per year after a median follow-up
of three years.2 This is comparable to the preference ofl Oncologist Nurse practitioner General Practitioner
B A B A B
50 32 58 5 6
50 68 42 95 94
0.003 0.81
cancer unit (1998e1999). Group B, consisted of patients operated after the
Table 5
Determinants of needs and preferences in follow-up.














Age 0.102 L0.437b L0.207a 0.081 0.023
T-Stage 0.005 0.096 0.002 0.035 0.150
Adjuvant endocrine therapy 0.098 0.24 0.027 0.128 0.137
Adjuvant chemotherapy 0.040 0.239 0.189 0.067 0.065
Radiotherapy 0.026 0.011 0.042 0.083 L0.202a
Duration follow-up 0.079 0.049 0.125 L0.406 b 0.087
Attitude towards follow-up
Communication (with caregiver) 0.168 0.019 0.132 0.075 0.042
Sense of reassurance 0.034 0.002 0.061 0.06 0.221 b
Nervous anticipation 0.231a 0.139 0.035 0.024 0.044
Specific perceived disadvantages 0.183 0.016 0.035 0.037 0.145
Fear of recurrence 0.115 0.236a 0.004 0.079 L0.211a
Patient satisfaction questionnaire (PSQ)
Technical competence 0.158 0.209 0.010 0.133 0.63
Interpersonal aspects 0.160 L0.283a 0.068 0.146 0.04
Access to care 0.180 L0.345b 0.23 0.173a 0.04
Total score 0.109 L0.298b 0.081 0.059 0.115
Quality of life
Quality of life on a visual scale L0.199a 0.168 0.196a 0.020 0.044
HADS anxiety 0.184 0.269a 0.037 0.053 0.054
HADS depression 0.106 0.185 0.030 0.082 0.077
B. Multivariable analysis, b’s
Age n.i. L0.37a 0.21 n.i. n.i.
T-Stage n.i. n.i. n.i. n.i. 0.08
Adjuvant endocrine therapy n.i. 0.13 n.i. n.i. n.i.
Adjuvant chemotherapy n.i. 0.06 0.082 n.i. n.i.
Radiotherapy n.i. n.i. n.i. n.i. 0.07
Duration follow-up n.i. n.i. n.i. L0.40 b n.i.
Attitude towards follow-up
Communication (with caregiver) 0.10 n.i. n.i. n.i. n.i.
Sense of reassurance n.i. n.i. n.i. n.i. 0.13
Nervous anticipation 0.02 n.i. n.i. n.i. n.i.
Specific perceived disadvantages 0.12 n.i. n.i. n.i. 0.16
Fear of recurrence n.i. 0.10 n.i. n.i. 0.13
Patient satisfaction questionnaire (PSQ)
Technical competence 0.17 0.26 n.i. n.i. n.i.
Interpersonal aspects 0.01 0.26 n.i. 0.02 n.i.
Access to care 0.06 0.15 n.i. 0.08 n.i.
Total score n.i. 0.17 n.i. n.i. n.i.
Quality of life
Quality of life on a visual scale 0.17 n.i. 0.20 n.i. n.i.
HADS anxiety 0.33 0.06 n.i. n.i. n.i.
HADS depression n.i. 0.08 n.i. n.i. n.i.
n.i. :variable not included in the multivariable model. ap<0.05, bp < 0.01.
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most 75% of these patients preferred visits more frequently
than once a year. In our study, after a median follow-up of
5.5 years, group A preferred significantly less frequent
follow-up visits than two years earlier. The difference be-
tween the two groups can be explained by the difference
in time since treatment, as the preferred frequency was sig-
nificantly correlated with follow-up duration in the multi-
variable analysis. The need for frequent follow-up
decreases over time, as almost two thirds of patientsindicated annual follow-up to be sufficient at 5.5 years after
treatment. However, the preference for life long follow-up
did not differ significantly between the groups and was
comparable to previous data.2
Multivariable analyses of determinants of needs and
preferences revealed only young age as independent predic-
tor for high specific informational needs, which is in line
with other studies.2,29 Longer time since diagnosis was
found to be an independent predictor of lower preferred
follow-up frequency. As opposed to previous studies,2,21
772 M. van Hezewijk et al. / EJSO 37 (2011) 765e773no correlation was found between informational needs and
high anxiety or depression scores.
The nurse practitioner in follow-up was well appreciated
by patients, as described previously.8,30,31 They were appre-
ciated significantly more by the group for whom the nurse
practitioner was part of standard care from the time of di-
agnosis, which was also shown by others.32LimitationsThis study was not a case control study, but patients in
group B were randomly selected from patients treated in
that time period. Nevertheless, we are convinced this pop-
ulation gives a good insight in the needs and preferences
of early breast cancer patients at two time points in
follow-up in general, and in the effect of the introduction
of the nurse practitioner in a breast care unit in particular.
The effect of the introduction of the breast cancer unit
and the difference in time since diagnosis between both
groups might be confounding factors, although multivari-
able analysis did not show a correlation between needs
and preferences and duration of follow-up. Patients with
a longer follow-up, and hence a perceived better prognosis,
might be more satisfied (since the cancer has not recurred),
which we did not find. Moreover, patients who perceive
they are at higher risk (more recent diagnosis), may feel ob-
liged to express a (socially desirable) positive attitude.
Furthermore, from our data, the increase in perceived
‘time taken’ and patient satisfaction in group B cannot be
distinguished between visits by NPs or physicians. The dif-
ference however may in our view well be explained by the
fact that most visits were performed by the NPs in this
group. Although they have the same scheduled time, NPs
have less other tasks than physicians and are not distracted
by other calls or clinical patients’ problems during the out-
patients’ clinic, enabling them to focus more on their pa-
tient. They are also easier to contact directly for patients
which may explain the increased perceive access to care.
Furthermore, due to their background and training, they
might have a bigger intrinsic motivation to talk more exten-
sively with patients.
Finally, there is a chance of response bias, as patients
who respond to the questionnaire might be more satisfied
with follow-up than those who did not respond and we
have no information of the non-responders.Future aspectsIn 2007, we implemented a tailored follow-up pro-
gramme in our breast cancer unit.33 In this tailored pro-
gramme, patients are followed with a frequency according
to their individual risk of local recurrence. Patients in this
tailored program also receive questionnaires on their needs,
preferences in and satisfaction with follow-up care. The
present study can be used as a baseline to evaluate patients’
perspective on this program.Furthermore, this study teaches us the caveats in the in-
formation to our patients, as 95% of patients still falsely be-
lieve that early detection of distant metastases will
contribute to their cure, and will ask for additional investi-
gations to detect these. More information on this subject is
needed to establish realistic expectations of follow-up care.
Conclusion
In our breast cancer unit, patients were satisfied with the
follow-up and the role of the nurse practitioner was highly
appreciated. Duration of follow-up correlated with pre-
ferred frequency, not with informational needs in follow-
up, only young age increased these needs.
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